Back to all Representative Matters
Mar 19, 2019

Eve & Co Enters into Credit Facility to Fund Expansion of Its Greenhouse Production Facility

Richard M. Kimel, Melanie Cole, Sean Green and Daniel Mahler

On March 19, 2019, Eve & Co Incorporated (TSX-V: EVE), through its wholly-owned subsidiary Natural MedCo Ltd., entered into an $18,700,000 construction facility with Royal Bank of Canada to fund the completion of a 780,000 sq. ft. expansion of its greenhouse production facility located in Middlesex County, Ontario.

The financing will help complete the ongoing expansion of Eve & Co’s facility from 220,000 sq. ft. to 1,000,000 sq. ft., making Eve & Co one of the largest cannabis producers in Canada. Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licenses under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and cannabis oil. Natural MedCo Ltd. was Canada’s first female founded licensed producer of medicinal marijuana and received its cultivation license from Health Canada in 2016.

Aird & Berlis LLP represented Eve & Co with a team comprised of Richard Kimel, Melanie Cole and Sean Green (Capital Markets), Andrew Biderman (Financial Services) and Daniel Mahler (Real Estate).

Related Representative Matters

Representative Matters
MediPharm Labs Completes $37.8 Million Private Placement Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Aaron Collins Jun 22, 2020 MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cann... MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, recently completed a private placement with an institutional investor for aggregate gross proceeds of $37,822,500.
Representative Matters
TD Bank Leads $64 Million Syndicated Credit Facilities Jill P. Fraser and Kyle B. Plunkett Oct 23, 2019 Sangoma Technologies Inc. and Sangoma U.S. Inc. entered into a syndicated loan agreement with certain Schedule 1 banks.
Representative Matters
MediPharm Labs Closes $38.7 Million Credit Facility with a Leading Canadian Schedule 1 Bank Aaron Collins and Randy T. Hooke Oct 10, 2019 MediPharm Labs Corp., a global leader in cannabis extraction, distillation, purification and cannabinoid isolation, through its wholly-owned subsidiary, MediPharm Labs Inc., closed a credit facility with a prominent Canadian Schedule 1 bank for an aggregate $38.7 m...